$AILE
iLearningEngines Inc

2022 Q4 Form 10-K Financial Statement

#000114036123015404 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $93.89M
YoY Change 44.82%
Gross Profit $215.3M
YoY Change 40.68%
Gross Profit Margin
Selling, General & Admin $428.1K $1.555M
YoY Change -49.38% -59.7%
% of Gross Profit 0.72%
Research & Development $97.44M
YoY Change 37.4%
% of Gross Profit 45.26%
Depreciation & Amortization $77.00K
YoY Change
% of Gross Profit 0.04%
Operating Expenses $428.1K $1.555M
YoY Change -49.38% -59.7%
Operating Profit -$1.555M
YoY Change -59.7%
Interest Expense $2.353M $3.946M
YoY Change 32359.03% 16597.0%
% of Operating Profit
Other Income/Expense, Net $800.0K $15.83M
YoY Change -11.6% 81.84%
Pretax Income $2.725M $14.27M
YoY Change 3991.89% 194.57%
Income Tax $484.7K $750.4K
% Of Pretax Income 17.78% 5.26%
Net Earnings $2.241M $13.52M
YoY Change 3264.19% 179.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 $0.38
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $146.0K $146.0K
YoY Change -44.42% -44.42%
Cash & Equivalents $146.0K
Short-Term Investments
Other Short-Term Assets $76.35K $76.35K
YoY Change -85.16% -85.16%
Inventory
Prepaid Expenses $76.35K
Receivables $44.11M
Other Receivables $0.00
Total Short-Term Assets $222.3K $222.3K
YoY Change -71.39% -71.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $290.7M $290.7M
YoY Change 1.12% 1.12%
Other Assets $7.683M
YoY Change
Total Long-Term Assets $290.7M $290.7M
YoY Change 1.12% 1.12%
TOTAL ASSETS
Total Short-Term Assets $222.3K $222.3K
Total Long-Term Assets $290.7M $290.7M
Total Assets $291.0M $291.0M
YoY Change 0.92% 0.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.064M $1.064M
YoY Change -9.68% -9.68%
Accrued Expenses $4.073M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.500M $1.500M
YoY Change 100.0% 100.0%
Long-Term Debt Due $8.138M
YoY Change 135.88%
Total Short-Term Liabilities $2.947M $2.947M
YoY Change 52.87% 52.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.17M $10.17M
YoY Change -53.87% -53.87%
Total Long-Term Liabilities $10.17M $10.17M
YoY Change -53.87% -53.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.947M $2.947M
Total Long-Term Liabilities $10.17M $10.17M
Total Liabilities $13.12M $13.12M
YoY Change -45.29% -45.29%
SHAREHOLDERS EQUITY
Retained Earnings -$12.48M
YoY Change -46.17%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.48M $277.8M
YoY Change
Total Liabilities & Shareholders Equity $291.0M $291.0M
YoY Change 0.92% 0.92%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $2.241M $13.52M
YoY Change 3264.19% 179.09%
Depreciation, Depletion And Amortization $77.00K
YoY Change
Cash From Operating Activities -$597.4K -$1.598M
YoY Change -31.07% -34.42%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $392.0K $731.2K
YoY Change -100.25%
Cash From Investing Activities $392.0K $731.2K
YoY Change -100.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 750.0K
YoY Change -100.0% -99.74%
NET CHANGE
Cash From Operating Activities -597.4K -1.598M
Cash From Investing Activities 392.0K 731.2K
Cash From Financing Activities 0.000 750.0K
Net Change In Cash -205.4K -116.7K
YoY Change 76.06% -148.48%
FREE CASH FLOW
Cash From Operating Activities -$597.4K -$1.598M
Capital Expenditures $0.00
Free Cash Flow -$1.598M
YoY Change -34.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
76350
CY2022Q4 us-gaap Assets Current
AssetsCurrent
222330
CY2021Q4 us-gaap Assets Current
AssetsCurrent
777224
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
290737917
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
287523634
CY2022Q4 us-gaap Assets
Assets
290960247
CY2021Q4 us-gaap Assets
Assets
288300858
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1063841
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1177911
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1500000
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
750000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2947251
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1927911
CY2022Q4 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10062500
CY2021Q4 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10062500
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
110000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11991250
CY2021Q4 us-gaap Liabilities
Liabilities
23981661
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
731214
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12477730
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23181522
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12477011
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
290960247
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
288300858
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1555038
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3858771
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1555038
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3858771
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3945497
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
23634
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15826747
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8703634
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13521299
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4844863
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13521299
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4844863
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3945497
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
23634
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11881250
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2436432
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2022 arrw Deferred Underwriting Fee Charged
DeferredUnderwritingFeeCharged
0
CY2021 arrw Deferred Underwriting Fee Charged
DeferredUnderwritingFeeCharged
10062500
CY2021Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
16392714
CY2021Q1 arrw Underwriting Fees
UnderwritingFees
5750000
CY2021Q1 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10062500
CY2022Q4 arrw Net Tangible Asset Threshold For Redeeming Public Shares
NetTangibleAssetThresholdForRedeemingPublicShares
5000001
CY2022 arrw Percentage Of Public Shares That Can Be Redeemed Without Prior Consent
PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent
0.15
CY2022 arrw Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
1
CY2022 arrw Stock Conversion Ratio
StockConversionRatio
1
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 arrw Stock Conversion Ratio
StockConversionRatio
1
CY2022Q4 arrw Stock Conversion As Converted Percentage
StockConversionAsConvertedPercentage
0.20
CY2022Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022 arrw Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P15D
CY2022Q4 arrw Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022 arrw Threshold Trading Days
ThresholdTradingDays
P20D
CY2022 arrw Threshold Consecutive Trading Days
ThresholdConsecutiveTradingDays
P30D
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
37304
CY2022Q4 arrw Deferred Tax Assets Startup Or Organizational Expenses
DeferredTaxAssetsStartupOrOrganizationalExpenses
890822
CY2021Q4 arrw Deferred Tax Assets Startup Or Organizational Expenses
DeferredTaxAssetsStartupOrOrganizationalExpenses
608832
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
890822
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
646136
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
890822
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
646136
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
750410
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-244686
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-645774
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
244686
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
645774
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
750410
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
175916
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
244686
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001835972
CY2022 arrw Period To Redeem Public Shares If Business Combination Is Not Completed Within Initial Combination Period
PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
P10D
CY2021 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
CY2022 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
ARROWROOT ACQUISITION CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity File Number
EntityFileNumber
001-835972
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3961600
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
4553 Glencoe Ave, Suite 200
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Marina Del Rey
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90292
CY2022 dei City Area Code
CityAreaCode
310
CY2022 dei Local Phone Number
LocalPhoneNumber
566-5966
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
282037500
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2022Q4 us-gaap Cash
Cash
145980
CY2021Q4 us-gaap Cash
Cash
262671
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
514553
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
383410
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2022Q4 us-gaap Liabilities
Liabilities
13119751
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-23180803
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
11881250
CY2021 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
8680000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14271707
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4844863
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
750410
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
28276
CY2021 arrw Redeemable Ordinary Shares Accretion To Redemption Value
RedeemableOrdinarySharesAccretionToRedemptionValue
28713942
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
660000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4844863
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-23180803
CY2022 arrw Redeemable Ordinary Shares Accretion To Redemption Value
RedeemableOrdinarySharesAccretionToRedemptionValue
2817507
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13521299
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12477011
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8680000
CY2022 arrw Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2021 arrw Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
760022
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-438203
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
514553
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-114070
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1176870
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
383410
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1597905
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
287500000
CY2022 arrw Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
731214
CY2021 arrw Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-287500000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
281750000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8250000
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
149992
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
149992
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
750000
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
750000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
572862
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
750000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
290177138
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-116691
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
240706
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262671
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21965
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145980
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262671
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
367000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2021Q1 arrw Other Offering Costs
OtherOfferingCosts
580214
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
287500000
CY2021Q1 arrw Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10
CY2021Q1 arrw Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10
CY2022Q4 us-gaap Cash
Cash
145980
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
290737917
CY2022Q4 arrw Working Capital Deficit
WorkingCapitalDeficit
-2687921
CY2022Q4 arrw Investment Income Interest Cumulative Amount
InvestmentIncomeInterestCumulativeAmount
3945497
CY2022 arrw Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
731214
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt;">Use of Estimates</div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div> <div style="text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</div>
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
16392714
CY2021 arrw Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
760022
CY2022 arrw Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
CY2022 arrw Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 arrw Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
22625000
CY2022 arrw Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
CY2022 arrw Notice Period To Redeem Warrants
NoticePeriodToRedeemWarrants
P30D
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">Concentration of Credit Risk</div> <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify;"><span style="font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows</span>.</div>
CY2021Q1 arrw Number Of Director Nominees
NumberOfDirectorNominees
3
CY2021Q1 arrw Deferred Underwriter Fee Per Unit
DeferredUnderwriterFeePerUnit
0.35
CY2021Q1 arrw Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10062500
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
645774
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 arrw Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercent
-0.175
CY2021 arrw Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercent
-0.376
CY2022 arrw Effective Income Tax Rate Reconciliation Transaction Costs Allocable To Warrant Liabilities Percent
EffectiveIncomeTaxRateReconciliationTransactionCostsAllocableToWarrantLiabilitiesPercent
0
CY2021 arrw Effective Income Tax Rate Reconciliation Transaction Costs Allocable To Warrant Liabilities Percent
EffectiveIncomeTaxRateReconciliationTransactionCostsAllocableToWarrantLiabilitiesPercent
0.033
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.133
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.052
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 arrw Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
731214

Files In Submission

Name View Source Status
arrw-20221231_lab.xml Edgar Link unprocessable
0001140361-23-015404-index-headers.html Edgar Link pending
0001140361-23-015404-index.html Edgar Link pending
0001140361-23-015404.txt Edgar Link pending
0001140361-23-015404-xbrl.zip Edgar Link pending
arrw-20221231.xsd Edgar Link pending
brhc10049542_10k.htm Edgar Link pending
brhc10049542_ex31-1.htm Edgar Link pending
brhc10049542_ex31-2.htm Edgar Link pending
brhc10049542_ex32-1.htm Edgar Link pending
brhc10049542_ex32-2.htm Edgar Link pending
brhc10049542_ex4-5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
arrw-20221231_cal.xml Edgar Link unprocessable
arrw-20221231_def.xml Edgar Link unprocessable
arrw-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brhc10049542_10k_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending